Alan Coates

Position: Honorary Clinical Professor
Group: MFB L5 - Biostatistics
Phone: 9562 5057
Fax: 9562 5045
Location: Level 5
92-94 Parramatta Rd
Camperdown NSW 2050
Address: K25 - Medical Foundation Building
The University of Sydney
NSW 2006 Australia




Alan Coates graduated in Medicine from the University of Melbourne in 1966, and trained at the Royal Melbourne Hospital and the Walter and Eliza Hall Institute for Medical Research in Australia, then at the Wisconsin Clinical Cancer Center in the United States. After returning to Australia in 1978 he practised as a medical oncologist in Sydney. He was appointed Associate Professor in Cancer Medicine in the University of Sydney in 1985. Since 1998 he has been a Clinical Professor in the School of Public Health and the NHMRC Clinical Trials Centre in the University of Sydney.



  • Medical oncology
  • Clinical trials
  • Quality of life
  • Biostatistics

Committee Memberships:

Chair of AGITG's independent data safety and monitoring committee.

Member, Scientific Committee, International Breast Cancer Study Group

Member, Scientific Advisory Committee, Australian New Zealand Breast Cancer Trials Group

CV and publications:

Professor Coates' research interests include clinical trials in breast cancer and studies of quality of life in cancer patients. Professor Coates was president of the Clinical Oncological Society of Australia in 1994 and 1995. From 1998 to 2006 he was chief executive officer of the Cancer Council Australia. He was the first elected non-US member of the board of directors of the American Society of Clinical Oncology. He was chairman of the scientific advisory committee of the Australian New Zealand Breast Cancer Trials Group from 1985 to 2005 and remains co-chairman of the scientific committee of the International Breast Cancer Study Group. He is a visiting scientist at the Garvan Institute for Medical Research, attached to the breast cancer marker discovery group.

Awards include Member of the Order of Australia (AM) in 2002 for 'service to medicine in the field of oncology, particularly through breast cancer research', the Medical Oncology Group of Australia Pierre Fabre Cancer Achievement Award in 2003, and in 2006 the ASCO Distinguished Service Award for Scientific Leadership, the gold medal of the Australian Cancer Society, the Tom Reeve Oration Award of the Clinical Oncological Society of Australia and the gold medal of the Australian-New Zealand Breast Cancer Trials Group.

Back to search results